You or your company want to set up a Research & Development collaboration with one of the knowledge institutes? Do you want to get in touch with a particular researcher or research team? IXA offers a single point of entry for engaging with all Amsterdam academic research. We are the intermediary for the Amsterdam research landscape, connecting you to the researchers and facilities of Amsterdam UMC, Amsterdam University of Applied Sciences (HvA), University of Amsterdam (UvA), and Vrije Universiteit Amsterdam (VU).
You can contact us with questions such as:
Get in contact with one of our business developers. They have expertise across all sciences, helping you connect with the right people quickly and efficiently. At IXA we strongly believe in building effective and mutually beneficial partnerships, based on a personal and tailor-made approach. Each organization, each contact and each question is unique and should to be treated as such. We can help to strengthen your innovative power.
A new spin-off of Amsterdam UMC, location AMC, HaemoPulse, started in the first months of 2019. HaemoPulse will develop non-invasive optical technology for continuous real-time monitoring of blood hematocrit. Being able to measure hematocrit in such a manner opens a wide range of clinical applications, such as tracking of fluid balance in critically ill patients […]News
New elective : Entrepreneurship for Artificial Intelligence and Computer Science In recent years, academic entrepreneurship education has shifted from the exclusive domains of business administration and economics to many other domains as well. In April/May 2019, entrepreneurship is taught for the first time to students of the master Computer Science (joint degree of the Vrije […]News
The Dutch healthtech company Nico.lab prepares for an IPO in Australia after the company has previously collected 3 million euros from Australian investors. In addition, Nico.lab will enter the US market. Nico.lab is the result of a collaboration between Amsterdam UMC and health tech venture builder NLC. With years of intensive clinical research in the […]News